Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20230821001Phase 2Completed
A Phase 2 trial of melatonin, clonidine in Insomnia, attention deficit hyperactivity disorder (ADHD), sponsored by Phramongkutklao Hospital Foundation. Started Jul 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20230821001.